Correlation Between VIRI Old and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both VIRI Old and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIRI Old and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VIRI Old and Biodexa Pharmaceticals, you can compare the effects of market volatilities on VIRI Old and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIRI Old with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIRI Old and Biodexa Pharmaceticals.
Diversification Opportunities for VIRI Old and Biodexa Pharmaceticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between VIRI and Biodexa is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VIRI Old and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and VIRI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIRI Old are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of VIRI Old i.e., VIRI Old and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between VIRI Old and Biodexa Pharmaceticals
If you would invest (100.00) in VIRI Old on December 28, 2024 and sell it today you would earn a total of 100.00 from holding VIRI Old or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
VIRI Old vs. Biodexa Pharmaceticals
Performance |
Timeline |
VIRI Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Biodexa Pharmaceticals |
VIRI Old and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with VIRI Old and Biodexa Pharmaceticals
The main advantage of trading using opposite VIRI Old and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIRI Old position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.VIRI Old vs. LMF Acquisition Opportunities | VIRI Old vs. ZyVersa Therapeutics | VIRI Old vs. Sonnet Biotherapeutics Holdings | VIRI Old vs. Revelation Biosciences |
Biodexa Pharmaceticals vs. Todos Medical | Biodexa Pharmaceticals vs. Vacasa Inc | Biodexa Pharmaceticals vs. Teleflex Incorporated | Biodexa Pharmaceticals vs. Akso Health Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |